N
Market Data
$3.10−$0.36 (−10.29%)
NRXP · Last trade
Prev Close
$3.45
Range (31d)
$3.10 – $3.67
Recent Filings
- 8-K187.9 KBNRX Pharmaceuticals, Inc.Sep 15, 9:17 PM ET·0001437749-26-030492
- 8-K2.9 MBNRX Pharmaceuticals, Inc.Sep 14, 8:00 AM ET·0001437749-26-030228
- 8-K204.1 KBNRX Pharmaceuticals, Inc.Aug 17, 8:00 AM ET·0001437749-26-028111
- 10-Q11.4 MBNRX Pharmaceuticals, Inc.Aug 14, 4:32 PM ET·0001437749-26-028027
- 8-K165.0 KBNRX Pharmaceuticals, Inc.Aug 7, 7:00 AM ET·0001437749-26-026428
- 8-K160.3 KBNRX Pharmaceuticals, Inc.Jul 22, 7:00 AM ET·0001437749-26-024037
- 8-K537.4 KBNRX Pharmaceuticals, Inc.Jun 4, 5:20 PM ET·0001437749-26-019576
- 8-K169.7 KBNRX Pharmaceuticals, Inc.Jun 2, 5:30 PM ET·0001437749-26-019196
- 8-K200.2 KBNRX Pharmaceuticals, Inc.Mar 24, 4:32 PM ET·0001437749-26-009611
- 10-K14.9 MBNRX Pharmaceuticals, Inc.Mar 23, 4:30 PM ET·0001437749-26-009418
Insiders
10- ABRAMS MICHAEL SChief Financial Officer
- ACKERMAN RICHARDDirector, President & CEO, 10% Owner
- Besthof RobertInterim CEO
- B Group, Inc.10% Owner
- Big Rock Partners Sponsor, LLC10% Owner
- BIRDOFF RICHARDDirector
- BRAC Lending Group LLC10% Owner
- Casper Joseph MichaelChief Operating Officer
- Daigneault AlessandraGeneral Counsel & Secretary
- Flynn Patrick JohnDirector
Tickers
Addresses
business
1201 ORANGE STREET SUITE 600
WILMINGTON, DE, 19801
mailing
1201 ORANGE STREET SUITE 600
WILMINGTON, DE, 19801
Former Names
- Big Rock Partners Acquisition Corp.2021-05-24